SAMHD1 somatic mutations have been identified in several cancers, including solid cancers such as glioblastoma [176], colorectal [177], lung [178], and pancreatic cancers [179] and blood-related malignancies such as CLL [180] and myeloma [181]. This evidence concerns the gene SAMHD1 and cancer.